Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Virgin Wines UK (VINO) by Steve Moore in ShareProphets
- Hold SEGRO (SGRO) by Jefferies
- Avoid Pennant International Group (PEN) by Steve Moore in ShareProphets
- Buy CMC Markets (CMCX) by Paul Summers in The Motley Fool
- Buy AstraZeneca (AZN) by LBBW
- Watch Empresaria Group (EMR) by Steve Moore in ShareProphets
- Buy Centamin (DI) (CEY) by Nigel Somerville in ShareProphets
- Neutral Ryanair Holdings (CDI) (0RYA) by UBS
- Buy Relx plc (REL) by UBS
- Sell Unilever (ULVR) by UBS
- Hold AstraZeneca (AZN) by DZ Bank
- Buy British American Tobacco (BATS) by Deutsche Bank
- Hold Hammerson (HMSO) by Deutsche Bank
- Buy Computacenter (CCC) by Jefferies
- Buy Man Group (EMG) by Goldman Sachs
- Sell Deliveroo Class (ROO) by Redburn
- Buy Unilever (ULVR) by Deutsche Bank
- Buy 3i Group (III) by Lauren Almeida in The Times - Tempus
- Overweight BT Group (BT.A) by Barclays
- Overweight IG Group Holdings (IGG) by Barclays
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 56 open tips for Avacta Group (AVCT)
| Latest Bid : 71.00p | Latest Ask : 73.00p |
| High Today : 74.00p | Low Today : 70.26p |
| This Years High : 159.60p | This Years Low : 39.75p |
| Volume : 1,243,577 | MKT Cap : £258.48M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-06-26 09:30:00 26/06/2024 | -60.00% |
| Hold | Deutsche Bank | Premium Only | 2024-06-19 07:24:00 19/06/2024 | 80.00% |
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 12.09% |
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 35.43% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 28.71% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.78% | 10/07/2024 |
| Latest Bid : 71.00p | Latest Ask : 73.00p |
| High Today : 74.00p | Low Today : 70.26p |
| This Years High : 159.60p | This Years Low : 39.75p |
| Volume : 1,243,577 | MKT Cap : £258.48M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-06-26 09:30:00 26/06/2024 | -60.00% |
| Hold | Deutsche Bank | Premium Only | 2024-06-19 07:24:00 19/06/2024 | 80.00% |
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 12.09% |
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 35.43% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 28.71% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000